Amphastar Pharmaceuticals, Inc. (AMPH) › Total AssetsAmphastar Pharmaceuticals, Inc. (AMPH) — Total AssetsAnnual figures by fiscal year, from SEC filings.2013: $338.75M2014: $389.37M2015: $390.14M2016: $427.74M2017: $451.07M2018: $513.56M2019: $586.97M2020: $631.24M2021: $671.53M2022: $741.99M2023: $1.51B2024: $1.58B2025: $1.63B$1.63B2013Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$1.63B+3.3%2024$1.58B+4.3%2023$1.51B+103.9%2022$741.99M+10.5%2021$671.53M+6.4%2020$631.24M+7.5%2019$586.97M+14.3%2018$513.56M+13.9%2017$451.07M+5.5%2016$427.74M+9.6%2015$390.14M+0.2%2014$389.37M+14.9%2013$338.75M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share